Searched for
NEXIUM
Dr Reddy's countersues AstraZeneca over purple pillDr Reddy's Laboratories, has filed a complaint in a US court alleging that AstraZeneca "knew" about its plans to use the same colour in the...20 Nov, 2015, 05.33 PM IST- Dr Reddy’s sues AstraZeneca over purple colour of Nexium genericAZ had asserted that its purple coloured pill is protected by three federal trademarks and the generic drug launched by Dr Reddy’s in Septe...20 Nov, 2015, 04.00 AM IST
- Dr Reddy's restrained from selling generic drug Nexium in US marketNexium is used to treat severe gastric diseases. The company said the order has been passed pending further hearing or trial.10 Nov, 2015, 04.08 PM IST
- Sun Pharma withdraws lawsuit filed by Ranbaxy against USFDAThe lawsuit challenged FDA's revocation of Ranbaxy's tentative approvals for its generic versions of Nexium and Valcyte in the US, it added.09 Oct, 2015, 01.45 PM IST
- Dr Reddy's climbs as drug maker launches Nexium's genericFollowing the development, the DRL stock surged 6.32 per cent to hit a high of Rs 4,222.75. The scrip was nearly 3 per cent away from its 5...28 Sep, 2015, 04.01 PM IST
- Dr Reddy's launches Nexium generic in US marketDrug major Dr Reddy's Laboratories (DRL) has launched the generic version of Astrazeneca's Nexium, used to treat acid reflux, in the US mar...28 Sep, 2015, 12.21 PM IST
- Ranbaxy loses approvals, exclusivity of two drugs in USIn November, Ranbaxy had sued USFDA over revoking an approval to sell generic versions of Nexium and Valcyte in the US.03 Mar, 2015, 04.08 PM IST
- Ranbaxy forfeits 180 days exclusivity for generic NexiumRanbaxy said USFDA has determined that it has forfeited its 180-day exclusivity to sell generic version of digestive disorder medicine Nexi...28 Jan, 2015, 04.22 AM IST
- AstraZeneca-Ranbaxy drug settlement not anti-competitive"All parties have appellate rights. Two cases making similar allegations were filed by numerous purchasers in the state court in Pennsylvan...06 Dec, 2014, 08.08 PM IST
- US court refuses Ranbaxy appeal to block ANDA nod for 2 drugsRanbaxy Laboratories had sued USFDA over revoking an approval to sell generic versions of Nexium and Valcyte in the US market.26 Nov, 2014, 02.06 PM IST
- Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies"FDA has no power to correct an alleged mistake it made six years ago," Ranbaxy said in the court filing dated Nov. 14 and seen by Reuters ...19 Nov, 2014, 09.34 AM IST
- Ranbaxy Laboratories loses six months exclusivity on Roche's antiviral drug Valcyte"Ranbaxy is disappointed with this development & is actively evaluating all available options to preserve its rights," company said in a st...07 Nov, 2014, 12.29 PM IST
- Connecticut AG George Jepsen to USFDA: Pull up Ranbaxy for failing to launch drug NexiumRanbaxy was scheduled to launch the generic version of drug Nexium in US under a 6-month exclusive marketing opportunity, but it failed to ...13 Sep, 2014, 04.00 AM IST
- Cipla gets patent for Nexium, Fosamax modified versionsDomestic pharma major Cipla has received product patents for new forms of two blockbuster drugs-Osemaprazole and Alendronate-from the India...01 Jul, 2008, 01.44 AM IST
- Ranbaxy strikes deal on Nexium with AstraZenecaRanbaxy has entered into a series of out-of-court settlements with AstraZeneca with estimates of a revenue upside of $1.25-1.5 billion. Go ...16 Apr, 2008, 02.00 AM IST
- Ranbaxy to sell ulcer drug Nexium in USRanbaxy Pharmaceuticals Inc, a wholly-owned subsidiary of Ranbaxy Laboratories Ltd, has announced that it has reached an agreement with pha...15 Apr, 2008, 03.07 PM IST
- Ranbaxy gets tentative FDA nod for ulcer drugNexium is the second largest selling drug in the world and has annual sales of $5.5 billion in the US market alone.08 Feb, 2008, 12.00 AM IST
Load More
